Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 19610146)

1.

Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation.

Kamar N, Lavayssière L, Muscari F, Selves J, Guilbeau-Frugier C, Cardeau I, Esposito L, Cointault O, Nogier MB, Peron JM, Otal P, Fort M, Rostaing L.

World J Gastroenterol. 2009 Jul 21;15(27):3426-30.

2.

Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.

Marques ID, Ramalho J, David DR, Nahas WC, David-Neto E.

Int Urol Nephrol. 2014 Oct;46(10):2053-4. doi: 10.1007/s11255-014-0792-0. Epub 2014 Jul 31. No abstract available.

PMID:
25080208
3.

Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.

Iso Y, Sawada T, Kita J, Shiraki T, Sakuraoka Y, Kato M, Shimoda M, Kubota K.

Hepatogastroenterology. 2013 Oct;60(127):1624-6.

PMID:
24634932
4.

Plasmapheresis combined with rituximab for refractory idiopathic membranous nephropathy.

Wen M, Küchle C, Sarkar O, Renders L, Heemann U, Schmaderer C.

Int Urol Nephrol. 2014 Apr;46(4):847-8. doi: 10.1007/s11255-014-0673-6. Epub 2014 Mar 1. No abstract available.

PMID:
24585365
5.

Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.

Kheradmand T, Anthony TL, Harland RC, Testa G, Hart J, Renz J, Te HS, Marino SR.

Hum Immunol. 2014 Jun;75(6):578-83. doi: 10.1016/j.humimm.2014.02.010. Epub 2014 Feb 12.

PMID:
24530823
6.

Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.

Soin AS, Raut V, Mohanka R, Rastogi A, Goja S, Balachandran M, Saigal S, Saraf N, Bhangui P, Sumana KR, Singla P, Srinivasan T, Choudhary N, Tiwari A, Raina V, Govil D, Mohan N, Vohra V.

Indian J Gastroenterol. 2014 Jan;33(1):72-6. doi: 10.1007/s12664-013-0424-0. Epub 2013 Dec 27.

PMID:
24369388
7.

Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.

Egawa H, Teramukai S, Haga H, Tanabe M, Mori A, Ikegami T, Kawagishi N, Ohdan H, Kasahara M, Umeshita K.

Am J Transplant. 2014 Jan;14(1):102-14. doi: 10.1111/ajt.12520. Epub 2013 Nov 26.

8.

Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade.

Jawitz OK, G Jawitz N, Yuh DD, Bonde P.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1239-45; discussion 1245-6. doi: 10.1016/j.jtcvs.2013.06.040. Epub 2013 Aug 24.

PMID:
23978472
9.

Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.

Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.

Hum Immunol. 2013 Sep;74(9):1111-8. doi: 10.1016/j.humimm.2013.06.022. Epub 2013 Jun 18.

PMID:
23792054
10.

ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study.

Mendes M, Ferreira AC, Ferreira A, Remédio F, Aires I, Cordeiro A, Mascarenhas A, Martins A, Pereira P, Gloria H, Perdigoto R, Veloso J, Ferreira P, Oliveira J, Silva M, Barroso E, Nolasco F.

Transplant Proc. 2013 Apr;45(3):1110-5. doi: 10.1016/j.transproceed.2013.02.012.

PMID:
23622639
11.

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.

Puisset F, White-Koning M, Kamar N, Huart A, Haberer F, Blasco H, Le Guellec C, Lafont T, Grand A, Rostaing L, Chatelut E, Pourrat J.

Br J Clin Pharmacol. 2013 Nov;76(5):734-40. doi: 10.1111/bcp.12098.

12.

Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.

Soejima Y, Muto J, Matono R, Ninomiya M, Ikeda T, Yoshizumi T, Uchiyama H, Ikegami T, Shirabe K, Maehara Y.

Clin Transplant. 2013 Mar-Apr;27(2):227-31. doi: 10.1111/ctr.12060. Epub 2013 Jan 7.

PMID:
23293980
13.

Bleeding complications in pediatric ABO-incompatible kidney transplantation.

Schaefer B, Tönshoff B, Schmidt J, Golriz M, Mehrabi A, Gombos P, Morath C, Wühl E, Schaefer F, Schmitt CP.

Pediatr Nephrol. 2013 Feb;28(2):327-32. doi: 10.1007/s00467-012-2302-x. Epub 2012 Sep 9.

PMID:
22961637
14.

ABO-incompatible kidney transplantation: first cases in Turkey.

Tuncer M, Yücetin L, Tekin S, Demirbas A.

Transplant Proc. 2012 Jul-Aug;44(6):1703-5. doi: 10.1016/j.transproceed.2012.04.016.

PMID:
22841248
15.

Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature.

Maitta RW, Choate J, Emre SH, Luczycki SM, Wu Y.

J Clin Apher. 2012;27(6):320-9. doi: 10.1002/jca.21244. Epub 2012 Jul 26. Review.

PMID:
22833397
16.

ABO-incompatible kidney transplantation in elderly patients over 60 years of age.

Uchida J, Iwai T, Machida Y, Kuwabara N, Kabei K, Murao M, Otoshi T, Naganuma T, Kumada N, Nakatani T.

Int Urol Nephrol. 2012 Oct;44(5):1563-70. doi: 10.1007/s11255-012-0231-z. Epub 2012 Jul 25.

17.

Determination of rituximab dose according to immunologic risk in ABO-incompatible kidney transplantation.

Chung BH, Hong YA, Sun IO, Piao SG, Kim JI, Moon IS, Choi BS, Park CW, Kim YS, Yang CW.

Ren Fail. 2012;34(8):974-9. doi: 10.3109/0886022X.2012.700892. Epub 2012 Jul 20.

PMID:
22817654
18.

ABO-incompatible kidney transplantation.

Fehr T, Stussi G.

Curr Opin Organ Transplant. 2012 Aug;17(4):376-85. doi: 10.1097/MOT.0b013e328355f013. Review.

PMID:
22790072
19.

Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.

Hirai T, Kohei N, Omoto K, Ishida H, Tanabe K.

Transpl Int. 2012 Sep;25(9):925-34. doi: 10.1111/j.1432-2277.2012.01518.x. Epub 2012 Jul 6.

PMID:
22764746
20.

Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.

Nakamura Y, Hama K, Iwamoto H, Yokoyama T, Kihara Y, Konno O, Jojima Y, Shimazu M.

Transplant Proc. 2012 Mar;44(2):565-9. doi: 10.1016/j.transproceed.2012.01.029.

PMID:
22410070
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk